BlackRock’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
64,400
+35,325
| +121% | +$115K | ﹤0.01% | 4591 |
|
|
2025
Q1 | $59.6K | Hold |
29,075
| – | – | ﹤0.01% | 4831 |
|
|
2024
Q4 | $64K | Hold |
29,075
| – | – | ﹤0.01% | 4834 |
|
|
2024
Q3 | $49.1K | Hold |
29,075
| – | – | ﹤0.01% | 4765 |
|
|
2024
Q2 | $70.9K | Buy |
29,075
+4
| +0% | +$10 | ﹤0.01% | 4733 |
|
|
2024
Q1 | $137K | Hold |
29,071
| – | – | ﹤0.01% | 4607 |
|
|
2023
Q4 | $134K | Hold |
29,071
| – | – | ﹤0.01% | 4666 |
|
|
2023
Q3 | $75.6K | Hold |
29,071
| – | – | ﹤0.01% | 4845 |
|
|
2023
Q2 | $141K | Sell |
29,071
-8,454
| -23% | -$40.9K | ﹤0.01% | 4741 |
|
|
2023
Q1 | $247K | Buy |
37,525
+272
| +0.7% | +$1.79K | ﹤0.01% | 4633 |
|
|
2022
Q4 | $414K | Sell |
37,253
-27,601
| -43% | -$306K | ﹤0.01% | 4574 |
|
|
2022
Q3 | $480K | Sell |
64,854
-378
| -0.6% | -$2.8K | ﹤0.01% | 4653 |
|
|
2022
Q2 | $391K | Buy |
65,232
+12,683
| +24% | +$76K | ﹤0.01% | 4762 |
|
|
2022
Q1 | $1.29M | Buy |
52,549
+1,004
| +2% | +$24.6K | ﹤0.01% | 4493 |
|
|
2021
Q4 | $2.46M | Buy |
+51,545
| New | +$2.46M | ﹤0.01% | 4253 |
|